Nanthealth, inc. (NH)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15Jun'15
Revenue
Revenue

93,932

95,961

91,113

91,049

87,410

89,464

0

0

0

-

0

0

-

-

-

-

-

-

-

Software-as-a-service related

-

-

-

-

-

-

-

-

-

-

-

-

6,674

6,750

11,381

13,258

0

0

0

Software and hardware related

-

-

-

-

-

-

-

-

-

-

-

-

57,306

56,210

47,025

36,437

0

0

0

Maintenance

-

-

-

-

-

-

-

-

-

-

-

-

7,970

9,089

12,526

13,092

0

0

0

Total software-related revenue

-

-

-

-

-

-

-

-

-

-

-

-

65,999

62,960

58,406

49,695

0

0

0

Sequencing and molecular analysis

-

-

-

-

-

-

-

-

-

-

-

-

1,114

604

197

120

0

0

0

Home health care services

-

-

-

-

-

-

-

-

-

-

-

-

6,993

7,751

14,879

14,191

0

0

0

Total net revenue

-

-

-

-

-

-

-

-

-

-

-

-

80,057

80,404

86,008

77,098

0

0

0

Cost of Revenue:
Total cost of revenue

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Software-as-a-service related

-

-

-

-

-

-

-

-

-

-

-

-

21,693

19,883

19,566

17,237

0

0

0

Software and hardware related

-

-

-

-

-

-

-

-

-

-

-

-

1,581

816

1,276

839

0

0

0

Maintenance

-

-

-

-

-

-

-

-

-

-

-

-

429

798

2,079

2,069

0

0

0

Amortization of developed technologies

-

-

-

-

-

-

-

-

-

-

-

-

5,954

8,492

13,111

13,313

0

0

0

Total software-related cost of revenue

-

-

-

-

-

-

-

-

-

-

-

-

25,178

20,699

20,842

18,076

0

0

0

Sequencing and molecular analysis

-

-

-

-

-

-

-

-

-

-

-

-

3,580

1,987

968

398

0

0

0

Home health care services

-

-

-

-

-

-

-

-

-

-

-

-

9,350

12,131

20,405

19,812

0

0

0

Cost of Revenue

-

-

0

0

-

-

0

0

0

-

31,435

29,999

42,587

44,107

57,405

53,668

0

0

0

Gross Profit

58,575

57,539

51,271

48,353

43,948

45,195

47,144

46,366

48,763

45,154

41,744

42,082

37,470

36,297

28,603

23,430

0

0

0

Operating Expenses
Selling, general and administrative

58,146

61,043

60,274

62,139

65,350

70,763

76,921

77,441

78,278

74,976

62,784

67,297

95,320

105,258

114,802

110,615

0

0

0

Research and development

18,772

19,072

18,043

18,310

19,615

20,916

24,686

27,600

30,087

33,862

27,385

29,596

45,542

47,310

52,003

47,003

0

0

0

Amortization of acquisition-related assets

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

-

-

-

-

Impairment of intangible assets

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Amortization of acquisition-related assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,377

0

0

0

Total operating expenses

84,925

88,309

86,511

88,643

89,182

95,896

105,823

109,257

112,581

113,054

92,866

99,590

144,318

156,785

172,247

161,995

0

0

0

Loss from operations

-26,350

-30,770

-35,240

-40,290

-45,234

-50,701

-58,679

-62,891

-63,818

-67,900

-51,122

-57,508

-106,848

-120,488

-143,644

-138,565

0

0

0

Interest expense, net

-18,287

-18,044

-17,798

-17,548

-17,337

-17,120

-16,884

-16,645

-16,396

-16,168

-13,807

-11,155

-8,900

-6,429

-4,670

-3,558

0

0

0

Other income (expense), net

334

-5,625

-21,987

-18,173

-20,561

-17,876

-436

-602

745

800

3,536

3,580

3,490

3,593

1,027

1,478

0

0

0

Income (Loss) from Equity Method Investments

-7,891

-8,317

-25,298

-106,621

-107,358

-108,409

-93,493

-13,129

-49,069

-50,334

-79,454

-79,116

-42,606

-40,994

-7,893

-5,434

0

0

0

Loss from continuing operations before income taxes

-52,194

-62,756

-100,323

-182,632

-190,490

-194,106

-169,492

-93,267

-128,538

-133,602

-140,847

-144,199

-154,864

-164,318

-155,180

-146,079

0

0

0

Provision for income taxes

-245

-112

-412

-1,663

-2,397

-3,673

-5,717

-3,909

-3,290

-2,203

-5,158

-5,133

-19,362

-23,797

-18,553

-18,608

0

0

0

Net loss from continuing operations

-51,949

-62,644

-99,911

-180,969

-188,093

-190,433

-163,775

-89,358

-125,248

-131,399

0

0

0

-

0

-

-

-

-

Income (loss) from discontinued operations, net of tax

32,175

-118

-225

-254

-1,814

-1,719

-888

-20,239

-31,016

-43,812

0

0

0

-

0

-

-

-

-

Net Income (Loss) Attributable to Parent

-19,774

-62,762

-100,136

-181,223

-189,907

-192,152

-164,663

-109,597

-156,264

-175,211

-213,528

-208,004

-192,072

-184,102

-147,109

-127,471

0

0

0

Continuing operations - common stock (in usd per share)

-0.08

-0.11

-0.15

-0.13

-0.18

-0.45

-0.89

-0.20

-0.20

-

-0.20

-0.48

-0.23

-

-

-

-

-

-

Discontinued operations - common stock (in usd per share)

0.29

0.00

0.00

0.00

0.00

-0.01

0.00

-0.01

0.00

-

-0.17

-0.10

-0.11

-

-

-

-

-

-

Total net income (loss) per share - common stock (in usd per share)

0.21

-0.11

-0.15

-0.13

-0.18

-0.46

-0.89

-0.21

-0.20

-

-0.37

-0.58

-0.34

-

-

-

-

-

-0.21

Weighted average shares outstanding
Basic and diluted - common stock (shares)

110,619

-

110,619

110,209

109,904

-

109,471

109,120

108,579

-

115,924

121,756

121,618

-

-

-

-

-

82,406

Software and hardware related
Revenue

-

-

0

0

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Cost of goods and services

-

-

0

0

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Maintenance
Net revenue

-

-

10,249

10,028

-

9,834

0

0

0

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

1,555

1,625

1,106

856

779

924

0

0

0

-

-

-

-

-

-

-

-

-

-

Total software-related revenue
Revenue

91,684

91,365

84,352

82,181

77,749

80,014

0

0

0

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

32,239

32,406

30,796

30,953

31,019

32,883

0

0

0

-

-

-

-

-

-

-

-

-

-

Software-as-a-service related
Revenue

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Amortization of developed technologies

-

-

0

0

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Sequencing and molecular analysis
Revenue

978

1,733

2,204

2,670

3,103

3,129

0

0

0

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

2,470

4,545

6,678

8,539

9,051

8,055

0

0

0

-

-

-

-

-

-

-

-

-

-

Home Health Care Services [Member]
Revenue

1,270

2,863

4,557

6,198

6,558

6,321

0

0

0

-

-

-

-

-

-

-

-

-

-

Total cost of revenue

648

1,471

2,368

3,204

3,392

3,331

0

0

0

-

-

-

-

-

-

-

-

-

-

Amortization of developed technologies
Total cost of revenue

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-